2.5 ML linvoseltamab-gcpt 2 MG/ML Injection [Lynozyfic]

Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.

Start free with Eleplan

Clinical drug

2.5 ML linvoseltamab-gcpt 2 MG/ML Injection [Lynozyfic]

2 MG/ML · Injection · injection

A form of linvoseltamab-gcpt →

2.5 ML linvoseltamab-gcpt 2 MG/ML Injection [Lynozyfic] — Other monoclonal antibodies and antibody drug conjugates. Strength, form, class, interactions & more.

2.5 ML linvoseltamab-gcpt 2 MG/ML Injection [Lynozyfic]

Active ingredient

linvoseltamab-gcpt →

Classification

Other monoclonal antibodies and antibody drug conjugatesBispecific B Cell Maturation Antigen-directed CD3 T Cell Engager

Drug interactions

Linvoseltamab-gcpt may increase the exposure of certain CYP substrates, leading to a higher risk of adverse reactions.

  • moderateCYP substrates — increased risk of adverse reactions

Source: RxNorm + openFDA + RxClass + FAERS · 2026

Look up another medication

Powered by Eleplan

A drug lookup is just the start. Eleplan keeps the whole care plan in one place.

Medications, diagnoses, documents, appointments, and the whole care team — organized and always in sync, with Ellie, your AI care assistant, on top of it. Free to start.

Get started freeSee how Eleplan works →